Climedo Connect
Patient Centricity and RWE – How Each Amplifies and Promotes the Other

October 17, 2024 | 3:00 – 4:00 PM CET 

RWE and Patient Centricity

Thursday, October 17, 2024 

We explored the growing importance of combining patient-centric research with real-world data to transform healthcare delivery and improve patient outcomes in our Climedo Connect webinar "Patient Centricity and Real-World Evidence (RWE)". 

While RWE tells us "what" is happening with diseases, treatments and outcomes, Patient Centricity explains both "which" changes occur and "why". By incorporating patient-reported data on unmet needs, treatment experiences and wearables, we can enhance healthcare services and improve patient wellbeing.

During the webinar on October 17, 2024 with Ella Balasa (advocate for patient engagement) and Dr. Chris Pashos (thought leader in the intersection of RWE and patient-centric healthcare), our experts shared their expertise and explored practical strategies for leveraging RWE and patient-centric data to drive more meaningful improvements in patient care.

What we discussed:

  • Why RWE and patient centricity are increasingly being recognized as critical to efforts to improve healthcare delivery and financing, and resulting patient outcomes.
  • How RWE and patient centricity complement each other when it comes to the “what" and "why" in diseases, treatments and outcomes.
  • How patient-reported data (including data from wearables) and overall experiences can enrich what is known and inform efforts to improve patient care and wellbeing. 

In addition to Ella's and Chris presentation, attendees had the opportunity to gain valuable insights and contribute to the discussion on enhancing patient centricity and RWE. 

Meet Our Speakers

Dragan
Dragan Mileski

Co-Founder and CTO
Climedo

Dragan, an IT specialist driven by entrepreneurship, co-founded Climedo in 2017 with a mission to enhance medical treatment using intelligent software solutions. As the Chief Technology Officer (CTO), he leads teams dedicated to developing cutting-edge software aimed at transforming post-market Real-World Evidence (RWE) studies, providing real-time transparency of outcomes and fostering engagement with healthcare professionals.


 

 

Ella-Balasa
Ella Balasa

Patient Advocacy and Engagement Consultant

Ella Balasa is a patient advocate, consultant and person with cystic fibrosis. She empowers patients and advances healthcare strategies by speaking publicly on patient perspectives and distilling clinical information. Working with healthcare organizations clinical trial development and sharing patient experiences, she raises awareness of rare diseases and promotes self-advocacy. Learn more at www.ellabalasa.com.

 

 

 

Chris-Pashos
Dr. Chris Pashos

Member, Board of Directors
Genesis Research

Chris is dedicated to improving patient care and outcomes. He has demonstrated leadership in academia, consulting and global life sciences companies, primarily using RWE, patient-centric research and other aspects of HEOR to support the development and commercialization of innovative therapies. Currently he serves on the Board of Directors of Genesis Research to support life sciences companies.

 

 

 

What was on the Agenda?

  • Intro (Dragan Mileski)

  • Patient Centricity and RWE – How Each Amplifies and Promotes the Other (Ella Balasa, Dr. Chris Pashos)

  • Discussion and networking (all)

  • Wrap-up (Dragan Mileski)

Your Takeaways

INSIGHTS

Valuable insights into the relationship between RWE and patient centricity.

BEST PRACTICES

Discover how technology can be used to efficiently capture real-time data.

NETWORKING & DISCUSSION

Talk to other industry professionals and find out how they are tackling challenges similar to yours.

CLIMEDO

The leading European eCOA system for non-interventional studies, RWE and launch success

Climedo offers an all-in-one eCOA and EDC solution with hybrid capabilities for non-interventional studies and real-world evidence. By using a patient-centric approach and leveraging real-time data insights and visualizations around a study’s current progress, Climedo empowers its clients to better engage with healthcare professionals and other key opinion leaders (KOLs). This boosts awareness, stimulates scientific dialogue and accelerates the launch success of new medical innovations, thus reaching more patients faster.

Founded in Munich in 2017, Climedo is a leading trusted partner for pharma, MedTech, CROs and academia with over 1.7 million patients enrolled to date. Learn more at www.climedo.com.

Climedo logo
Ecosystem2023